Dan Kemp

Company: ThyasEvade

Job title: Chief Executive Officer

Seminars:

iPSC Leaders Panel: Highlighting the Next Steps for the Future of iPSC-Derived Cell Therapies 8:50 am

Reflecting on how far the field has come to reaffirm iPSCs as the cornerstone of regenerative cell therapies Understanding the prospects of iPSC and laying out the trajectory to unite industry experts to propel regulatory approval Discussing the progression of, and clinical readiness for, iPSC technologies to identify areas in need of greater attentionRead more

day: Conference Day One